Aptevo Therapeutics Inc. financial statements
Aptevo Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 25.97M | 10-K |
| Cash and equivalents | USD 21.62M | 10-Q |
| Total debt | USD 4.63M | EODHD |
Aptevo Therapeutics Inc. financials on 6ix · Aptevo Therapeutics Inc. on 6ix